Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4 ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Urheber
-
Holmgaard, Rikke B.
- Beteiligte Personen und Organisationen
-
Zamarin, Dmitriy
Munn, David H.
Wolchok, Jedd D.
Allison, James P.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P77
- URN
-
urn:nbn:de:1111-2016072650467
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Holmgaard, Rikke B.
- Zamarin, Dmitriy
- Munn, David H.
- Wolchok, Jedd D.
- Allison, James P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study
Indoleamine 2,3-dioxygenase 1 versus Toxoplasma gondii - host species determines success
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study
Indoleamine 2,3-dioxygenase 1 versus Toxoplasma gondii - host species determines success
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study